A coronary sinus reducer implant, a small hourglass-shaped device inserted near the heart through keyhole surgery via the neck, has demonstrated effectiveness in treating refractory angina, a form of heart disease that persists despite standard medical interventions. Refractory angina affects an estimated 300,000 people in England and causes debilitating chest pain that significantly limits daily activities and quality of life.
A large-scale research study, the largest of its kind globally, analyzed outcomes for 491 patients with refractory angina between 2014 and 2024, with 474 receiving implants at 19 hospitals across England and Scotland. The study found that the device produced significant reductions in chest pain in 75% of patients within six months of implantation. The procedure is minimally invasive, with most patients returning home the same day or the following day, and serious complications proved rare.
The device works by narrowing a vein at the back of the heart, redirecting blood flow to heart muscle regions receiving insufficient oxygen. Each implant costs the NHS £11,400. Consultant cardiologist Dr. Ranil de Silva, who co-led the research, noted that the findings demonstrate the device can substantially improve quality of life and mental wellbeing while reducing hospital admissions. Patient testimonials describe transformative improvements in physical capability and emotional well-being following implantation.
Despite these promising results, researchers caution that the device remains experimental and should not yet be considered standard treatment for refractory angina. Dr. de Silva emphasized that additional trials and NHS funding approval are necessary to expand access. Currently, only a small fraction of eligible patients have received the implant. Clinical experts from organizations including the British Heart Foundation have characterized the findings as reassuring and noted the device offers meaningful hope for this patient population.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI